Related references
Note: Only part of the references are listed.Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4
Giorgia Colombo et al.
ISCIENCE (2022)
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (vol 38, pg 500, 2020)
Catherine S. Grasso et al.
CANCER CELL (2021)
NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Hongwei Lv et al.
CELL METABOLISM (2021)
A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages
Thomas B. Huffaker et al.
NATURE COMMUNICATIONS (2021)
Metabolic reprograming of tumor-associated macrophages
Abhishek Puthenveetil et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
Many ways to resistance: How melanoma cells evade targeted therapies
Ines Kozar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
Mickael Ohanna et al.
GENES & DEVELOPMENT (2018)
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Flavia Castro et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Dual Nature of Type I and Type II Interferons
Amanda J. Lee et al.
FRONTIERS IN IMMUNOLOGY (2018)
Melanoma treatment in review
Beatriz Domingues et al.
IMMUNOTARGETS AND THERAPY (2018)
Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
Jair Machado Espindola-Netto et al.
ONCOTARGET (2017)
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
Martina Musella et al.
ONCOIMMUNOLOGY (2017)
NAD+ Deficits in Age-Related Diseases and Cancer
Amanda Garrido et al.
TRENDS IN CANCER (2017)
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response
Jared A. Wallace et al.
BLOOD (2017)
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine
Ambra A. Grolla et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Katrina Meeth et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth
Jared Wallace et al.
PLOS ONE (2016)
Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation
Xiaodi Su et al.
NATURE IMMUNOLOGY (2015)
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
AMP-Activated Protein Kinase Restricts IFN-γ Signaling
Gordon P. Meares et al.
JOURNAL OF IMMUNOLOGY (2013)
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions
Elena Maldi et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth
W Hou et al.
CLINICAL CANCER RESEARCH (2005)
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation:: relevance for the immune modulatory effect in multiple sclerosis
B Schreiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Share Paper
